Search results
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
San Antonio Express-News· 1 day agoFederal regulators are challenging patents on 20 brand-name drugs, including the blockbuster...
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Associated Press· 2 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with...
Earnings call: Ashland Inc. reports mixed Q2 results amid sales dip
Investing.com· 4 hours agoThe company's adjusted EBITDA fell by 13% to $126 million, although it surpassed expectations....
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KTLA-TV Los Angeles· 1 day agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand-name drugs, including the...
Earnings call: Ashland Inc. reports mixed Q2 results amid sales dip By Investing.com
Investing.com· 8 hours agoThe company's adjusted EBITDA fell by 13% to $126 million, although it surpassed expectations....
US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Quartz· 2 days agoThe Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The ...
Q1 2024 Tenet Healthcare Corp Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 1 day agoOur balance sheet, which was once a challenged part of the Tenet's story has been deleveraged. This provides us with a strong foundation and a significant amount of capital ...
Tenet Healthcare Corporation (NYSE:THC) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 20 hours agoTenet Healthcare Corporation (NYSE:THC) Q1 2024 Earnings Call Transcript April 30, 2024 Tenet...
Breakthrough in brown fat research: Researchers have found brown fat's 'off-switch'
Science Daily· 3 days agoA new study from the research groups of Prof. Jan-Wilhelm Kornfeld from the University of Southern Denmark/the Novo Nordisk Center for Adipocyte Signaling (Adiposign) and ...
Ashland Inc (ASH) Q2 Fiscal 2024 Earnings: Surpasses EPS Estimates, Faces Revenue Decline
GuruFocus.com via Yahoo Finance· 1 day agoIn conclusion, Ashland's Q2 fiscal 2024 results reflect a resilient performance amidst market challenges, with significant growth in net income and EPS. The company's strategic adjustments and ...
